$3M for IntelligentMDx

Wade Roush6/29/09

IntelligentMDx, a Cambridge, MA, startup developing DNA- and RNA-based tests for a range of human diseases, announced last week that it has raised an additional $3 million from a group of unnamed, non-venture investors. The new funding brings the startup’s total capital pot to $26.5 million.

Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can subscribe to his Google Group or e-mail him at wroush@xconomy.com. Follow @